"The Benefits of SGLT2 Inhibitors in Cardiovascular Prevention, Glycemic Control and Weight Loss, in the Treatment of Diabetes"
written by Bruna de Souza Faustino, Alberto dos Reis Costa Junior, Letícia Nascimento Medeiros Bortolon, Larissa Bianca Paiva Cunha de Sá, Denise Rosso Tenório Wanderley Rocha, Alberto Krayyem Arbex,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.6 No.1, 2016
has been cited by the following article(s):
  • Google Scholar
  • CrossRef